Trump’s Medical Marijuana Rescheduling Is a Hollow Victory for Justice Reform

The Trump administration’s recent executive order to reclassify state-licensed medical marijuana from Schedule I to Schedule III drugs is being hailed by some as a step forward. But make no mistake: this policy shift is largely cosmetic and fails to address the urgent reality faced by thousands still serving federal prison sentences for marijuana-related offenses.

Signed by acting Attorney General Todd Blanche, the order removes medical marijuana from the same category as heroin, a move both the Obama and Biden administrations had considered but never enacted. While this change may ease tax burdens and regulatory hurdles for licensed growers and researchers, it does nothing to legalize marijuana or reduce penalties for possession and trafficking. Most importantly, it offers no relief to people currently imprisoned on cannabis charges.

Jason Ortiz of the Last Prisoner Project calls it “a victory,” but one where “the fight is far from over.” The majority of those behind bars are not locked up for simple possession but for large-scale trafficking or combined offenses, often receiving draconian sentences. Take Hector Ruben McGurk, serving life without parole since 2007 for transporting marijuana and money laundering. His family views his punishment as excessively harsh but remains powerless to secure his release.

Experts like Cat Packer from the Drug Policy Alliance emphasize that federal marijuana penalties are not solely tied to drug scheduling. Mandatory minimum sentences and other harsh laws remain intact regardless of this reclassification. Meanwhile, racial disparities persist: Black Americans are nearly four times more likely to be arrested for marijuana possession than white Americans, despite similar usage rates. Federal drug inmates are disproportionately Hispanic and Black, reflecting systemic bias.

The order’s benefits will likely flow to predominantly white-owned licensed cannabis businesses, exacerbating existing racial and economic inequities in the industry. Equity programs designed to support Black and brown entrepreneurs are unlikely to offset these advantages.

Unlike his broad pardons for January 6 rioters, Trump’s administration has not shown willingness to grant clemency for drug convictions. As Marta Nelson from the Vera Institute of Justice notes, marijuana convictions can serve political purposes, particularly in mass immigration enforcement.

Real change requires Congress and state lawmakers to act decisively to expunge convictions, reform sentencing, and ensure equitable access to the burgeoning cannabis market. Until then, this reclassification remains a superficial fix that leaves the core injustices of the drug war untouched.